Microfluidic Pneumatic Autoinjector Platform

Award Information
Agency: Department of Defense
Branch: Office for Chemical and Biological Defense
Contract: W911QY-13-P-0166
Agency Tracking Number: C131-106-0003
Amount: $99,835.00
Phase: Phase I
Program: SBIR
Awards Year: 2013
Solitcitation Year: 2013
Solitcitation Topic Code: CBD13-106
Solitcitation Number: 2013.1
Small Business Information
Physical Optics Corporation
Photonic Systems Division, 1845 West 205th Street, Torrance, CA, -
Duns: 153865951
Hubzone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: N
Principal Investigator
 Gregory Zeltser
 Principal Scientist
 (310) 320-3088
 psproposals@poc.com
Business Contact
 Gordon Drew
Title: Chief Financial Officer
Phone: (310) 320-3088
Email: gedrew@poc.com
Research Institution
N/A
Abstract
To address the U.S. CBD need for novel autoinjector technology that provides the warfighter with a compact, field-ready, cost-effective platform for long-term storage of any given CBT antidote that does not present a significant logistical burden, Physical Optics Corporation (POC) proposes to develop a Microfluidic Pneumatic Autoinjector (MPA) platform. The MPA will provide an innovative universal drug delivery platform that can provide long-term storage for next-generation CBT antidotes that is compact, lightweight, and robust for field use and enables autoinjection of wet-dry formulations in addition to single-component and multi-component wet formulations. The key components of the MPA include a novel design of the autoinjector and safety guards. These innovations will allow military personnel to self- or buddy-autoinject antidotes in full chem/bio protection gear. In Phase I, POC will demonstrate the feasibility of the MPA concept by developing a prototype that will meet the CBD performance metrics. POC plans to finalize the overall device design and manufacture and demonstrate the prototypes of the drug delivery system in Phase II. Also, POC will demonstrate to the DoD how this device is consistent with FDA guidelines and could be approved for drug injection via the 510(k) route.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government